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Abstract
Background: Puberty can affect vitamin D levels.
Objectives: The goal of this study was to analyze the rela-
tion between vitamin D deficiency and puberty in obese 
Spanish children, along with the possible interrelation 
between vitamin D status and degree of insulin resistance.
Methods: A cross-sectional study was carried out, in 
which clinical and biochemical data were gathered from 
120 obese and 50 normal weight children between January 
2011 and January 2013.
Results: Mean vitamin D levels were 19.5 and 31.6 ng/mL 
in obese pubertal and obese prepubertal children, respec-
tively. About 75% of the obese pubertal subjects and 46% 
of the obese prepubertal subjects had vitamin D deficiency. 
Vitamin D levels were significantly lower in pubescent sub-
jects compared with pre-pubescent subjects in summer, 
fall, and winter. There was no apparent relation between 
vitamin D levels and homeostasis model assessment index 
for insulin resistence (expressed in standard deviation score 
for sex and Tanner stage) in either puberty or pre-puberty.
Conclusion: Puberty may be a risk factor for the vitamin 
D deficiency commonly found in the obese child popula-
tion. This deficiency is not associated with higher insu-
lin resistance in obese pubertal children compared with 
obese prepubertal children.
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Introduction
In recent years, studies have found a high prevalence of 
vitamin D deficiency in the general population. Vitamin 
D has been shown to affect extraskeletal health, suggest-
ing that it plays a role in the prevention of autoimmune 
and vascular diseases as well as cancer. For these reasons, 
there has been an increased interest in investigating the 
role of vitamin D in a healthy body, and the long-term 
effects of vitamin D deficiency (1–3).
Vitamin D deficiency also affects children and ado-
lescents, especially those who are obese. Our team has 
demonstrated a 58% prevalence of vitamin D deficiency 
among obese children and adolescents. Furthermore, 
independently of the season, obese children showed sig-
nificantly lower vitamin D levels compared with normal-
weight children (4).
To date, the pathogenesis of vitamin D deficiency 
has been attributed to various factors, including adi-
posity level, race, season of the year, geographical area, 
level of sun exposure, and dietary intake (5). The fact that 
vitamin D deficiency is more frequent in adolescents than 
in prepubertal children (5, 6) suggests that puberty may 
be involved in the deficiency. However, there are few data 
in the literature regarding the influence of puberty on the 
vitamin D status of obese children and adolescents; more-
over, the possible correlation between vitamin D status 
and insulin resistance requires further clarification (6).
For these reasons, we hypothesized that obese pubertal 
children would exhibit greater vitamin D deficiency than 
prepubertal children. To test this hypothesis, we analyzed 
the relationship between vitamin D deficiency and puberty 
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in obese Spanish children, and sought to determine 
whether the deficiency had an impact on insulin resistance.
Materials and methods
Study design
A cross-sectional study of the prevalence of vitamin D deficiency was 
performed in the Pediatrics Department of Fundación Jiménez Díaz 
between January 2011 and January 2013.
Sample size calculation
Sample size was calculated with Ene 2.0 program. A minimum of 
96 obese children and adolescents were required for an estimated 
50% prevalence of vitamin D deficiency among obese children (7, 8), 
with a 10% accuracy (ω) and a 95% confidence interval as previously 
reported (4).
Subjects
The subjects included obese children and adolescents, with obesity 
defined as a body mass index (BMI) above the 97th percentile for 
individuals of the same age and sex (9). We also included a lean con-
trol group with BMI between the 10th and 85th percentiles. Patients 
with an existing medical condition and those using chronic medica-
tion were excluded.
Study variables
The sex, age, and race of all subjects were recorded. In addition, Tan-
ner staging was performed (10, 11), classifying Tanner Stage I as pre-
pubertal and Stages II to V as pubertal. Subjects were weighed (kg) 
to the nearest 0.1 kg using a Seca® electronic scale. Height (cm) was 
measured with a Harpender® stadiometer while each subject was 
standing. The minimal abdominal circumference between the xiphoid 
process and iliac crest was measured to determine the waist circum-
ference. Given that waist circumference changed with age, the waist-
standard deviation score (SDS) was also calculated for both genders 
(12). Blood pressure was measured in seated subjects with a Dinamap 
Procare Monitor. The average of the available measurements obtained 
from a single visit (up to three) was used for analysis. Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were also con-
verted into age- and sex-specific percentiles, which were converted 
to Z scores (13). BMI was calculated by applying the formula [weight 
(kg)/height (m)2] and expressed in both absolute values and in SDS for 
age and sex (9). After the first visit and following a 12-h fast, a blood 
sample was taken to determine 25-OH vitamin D (lean control group 
and obese children) and insulin levels (obese children).
Though not an accepted standard, the categories used to clas-
sify patients according to their 25-OH vitamin D plasma levels were as 
follows: deficient for patients with levels  < 20 ng/mL ( < 50 nmol/L), 
insufficient for levels of at least 20 but  < 30 ng/mL (50–75 nmol/L), 
and normal for levels  ≥  30 ng/mL ( ≥  75 nmol/L) (1).
We calculated the homeostasis model assessment (HOMA) 
index of insulin resistance as an absolute value and with SDS for sex 
and Tanner stage, which was calculated using reference values taken 
from the Spanish population (14).
Biochemical measurements
Levels of 25-OH vitamin D and insulin were determinated by chemi-
luminescence.
Statistical analysis
The data for the variables were expressed as mean values with the 
corresponding 95% confidence interval (95% CI). The Kolmogorov-
Smirnov test was used to ascertain the normal distribution of all the 
included variables. Student’s t-test was used to analyze the quan-
titative variables that had a normal distribution. A non-parametric 
Mann-Whitney U-test was used to analyze the quantitative variables 
that did not have a normal distribution. The χ2-test was used to com-
pare qualitative variables. Statistical analyses were performed using 
Statview (1998).
This study was approved by the Ethics and Clinical Trials 
Committee of the Fundación Jimenez Díaz, Institute for Biomedi-
cal Research. Informed consent was obtained from all the subjects’ 
patients or their guardians.
Results
Obese group
Data were collected from 120 obese children between 
the ages of 6 and 17 years. The clinical and biochemical 
data for both pubertal and prepubertal obese children are 
shown in Table 1. The vitamin D deficiency rate was 75% 
in the pubertal group and 46% in the prepubertal group. 
Vitamin D levels were significantly lower in pubertal 
obese subjects compared with their prepubertal counter-
parts (Table 1).
To control for seasonal influence, vitamin D levels 
were analyzed in the spring, summer, fall, and winter. By 
following this procedure, we observed that obese pubertal 
children showed significantly lower vitamin D levels in 
the summer, fall, and winter months compared with pre-
pubertal children (Figure 1). However, this difference was 
not observed in the spring. The highest and lowest levels 
of vitamin D were found in the summer and in the winter, 
respectively. No difference was observed in vitamin D 
levels between female and male children (Table 1).
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On the one hand, no significant differences were found 
by evaluating mean HOMA SDS in obese pubertal and pre-
pubertal children (Table 1). On the other hand, HOMA SDS 
levels in all obese children were significantly lower in the 
summer than in the spring and in the fall, although no 
such difference was found in the winter (Figure 2). No sig-
nificant differences were found between the other seasons. 
We also compared HOMA SDS for prepubertal and puber-
tal children in each season, and did not find significant dif-
ferences: 3.7 (2.1–4.3) vs. 3.4 (1.4–5.4) in fall, 3. 2 (2.2–4.4) 
vs. 3.3 (1.3–5.3) in winter, 2.7 (1.7–3.7) vs. 1.6 (0.9–2.3) in 
summer, and 2.7 (1.7–3.7) vs. 1.6 (0.9–2.3) in spring.
Obese prepubertal children with vitamin D deficiency 
( < 20 ng/mL) showed significantly higher HOMA SDS levels 
than obese prepubertal children with normal vitamin D 
status ( > 20 ng/mL): 4.4 (3.4–5.4) vs. 2.9 (2–3.8) (p < 0.05). 
However, obese pubertal children did not have significantly 
different HOMA SDS levels when compared according to their 
degree of vitamin D deficiency: 2.7 (1.6–3.8) vs. 1.4 (0.7–2.1).
Table 1 Clinical and biochemical characteristics of obese children.
  Prepubertal group 
n = 61
  Pubertal group 
n = 59
  p (prepubertal 
vs. pubertal)
Age, years   9.1 (8.5–9.7)  13.5 (13–14)   < 0.01
Male/female, %   67.2/32.8  45.7/54.3  ns
BMI SDS   2.9 (2.7–3.1)  2.9 (2.7–3.1)  ns
Waist circumference SDS   2.6 (2.4–2.8)  2.5 (2.3–2.7)  ns
HOMA SDS   3.8 (3.1–4.5)  2.7 (1.9–3.5)  ns
25-OH Vitamin D, ng/mL
  21.7 (19.1–24.3)  16.8 (14.5–19.1)   < 0.01
 Male   22.1 (18.8–25.3)  15.2 (12.3–18.1)   < 0.01
 Female   19.3 (15.2–23.4)  16.7 (13.4–20)  ns
 p (male vs. female)   ns  ns  (p = 0.06)
ns, not significant.
Figure 1 Comparison of vitamin D levels between prepubertal and 
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Figure 2 Comparison of HOMA SDS in obese children by season.
Finally, we conducted univariate analysis on vitamin 
D levels and HOMA SDS. We found no significant correla-
tion either by analyzing the data as a whole or by dividing 
the data into prepubertal and pubertal subjects.
Lean control group
Data were collected from 50 children (26 females and 
24 males) with a mean age of 10.44 years (9.61–11.27) and 
a mean BMI Z-score of –0.38 (–0.6 to –0.16). Among the 
subjects, 35 children were prepubertal (17 males and 
18 females). In the prepubertal lean control group, there 
was a prevalence of vitamin D deficiency of 11.4% (n = 4), 
of vitamin D insufficiency of 22.8% (n = 8), and a preva-
lence of normal values of vitamin D of 65.8% (n = 23). In 
the pubertal lean control group consisting of 15 children 
(7 males and 8 females), there was a prevalence of vitamin 
D deficiency of 6.6% (n = 1), of vitamin D insufficiency of 
40% (n = 6), and a prevalence of normal values of vitamin 
D of 53.4% (n = 8).
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Due to the reduced sample size of the lean control 
group, we decided to analyze data in two groups: autumn-
winter and spring-summer. In autumn-winter, the median 
values of vitamin D were significantly lower in the prepu-
bertal obese group (n = 37) than in the prepubertal lean 
control group (n = 17): 17 ng/mL (14.6–19.4) vs. 31.2 ng/mL 
(27–35.4). We also found significantly lower levels among 
pubertal obese children (n = 33) than in the pubertal 
control group (n = 8): 12.9 ng/mL (11–14.8) vs. 27.3 (20.8–
33.8). When we compared the prepubertal and pubertal 
control groups, we did not find differences in vitamin D 
levels: 31.1 ng/mL (26.4–35.8) vs. 25.1 ng/mL (19.5–30.7).
In spring to summer, the median values of vitamin D 
were significantly lower in the prepubertal obese group 
(n = 28) than in the prepubertal lean control group (n = 18): 
25.8 ng/mL (21.5–30.1) vs. 34.2 ng/mL (29.4–39.2). We also 
found significantly lower levels among pubertal obese 
children (n = 22) than in the pubertal control group (n = 7): 
22.3 ng/mL (18.4–26.2) vs. 32.7 ng/mL (29.9–35.5). When we 
compared the prepubertal and pubertal control group, we 
did not find differences in vitamin D levels: 34.3 ng/mL 
(29.4–39.2) vs. 32.7 ng/mL (29.9–35.5).
Pubertal stage
Finally, we analyzed the mean vitamin D status according 
to the pubertal stage in the obese group and in the lean 
control group (Table 2) without distinction of the season 
of the year. We found differences in vitamin D levels in 
Tanner II and III-IV with regards to Tanner Stage I in the 
obese group. We did not find differences in vitamin D 
levels among the different stages in the lean control group.
Discussion
To the best of our knowledge, no previous studies con-
ducted in different seasons of the year have analyzed the 
influence of puberty on vitamin D levels in obese Spanish 
children, and the possible connection between puberty 
and insulin resistance. In this study, we observed a higher 
prevalence of vitamin D deficiency in obese pubertal chil-
dren than in obese prepubertal children.
Adolescence is a critical stage for growth, develop-
ment, and bone formation. Thus, vitamin D requirements 
increase during puberty. Therefore, a vitamin deficiency 
during this period could affect both calcium absorption 
and bone formation (15, 16).
Numerous studies aimed to evaluate the prevalence of 
vitamin D in different populations. Vitamin D deficiency 
was more frequent in adolescents than in prepubertal 
children (17, 18), as seen in nationwide studies in Great 
Britain, the USA, and New Zealand. In childhood, the 
prevalence of vitamin D deficiency increases at older ages, 
and the risk of presenting this deficiency is highest during 
adolescence. A study conducted in Great Britain showed 
that 7% of British children between 1.5 and 10  years of 
age had 25-OH vitamin D levels of lower than 10 ng/mL, 
while 16% of adolescents between 11 and 18 years of age 
showed a deficiency at some point during the year (these 
figures doubled when the study was conducted in winter) 
(19). In other European countries (20), the USA (21), New 
Zealand (18) and Lebanon (22), studies showed high rates 
of vitamin D deficiency in adolescents (46%–92%), espe-
cially during winter months.
These results are consistent with the data available 
on normal-weight adolescents. Thus, the risk of vitamin 
D deficiency was proven to be higher in puberty in most 
populations analyzed (5, 22, 23). Due to the reduced 
sample size of the lean control group in our study, we 
cannot extrapolate results, but it seems that there is a 
trend toward higher vitamin D deficiency and insuffi-
ciency among pubertal children.
In obese children, this increased risk of vitamin D 
deficiency during puberty does not seem to be related 
to differences in indirect parameters of adiposity, which 
include BMI SDS and waist SDS. Additionally, the 










n  25-OH-Vitamin D n  25-OH-Vitamin D
I   59  21.8 (19.2–24.4)    35  33.1 (29.7–36.5) 
II   12  15.5 (9.5–21.5)  a   3  33.2 (31.2–35.2)  ns
III, IV   33  16.4 (13.7–19.1)  b   8  25.9 (20.0–31.8)  ns
V   16  20.6 (15.6–25.6)  ns   4  28.7 (23.0–34.4)  ns
Comparison between Tanner stages of each group (lean control and obese). ap < 0.05 between Tanner II and Tanner I, bp < 0.05 between 
Tanner III-IV and Tanner I, ns, not significant.
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difference between pubertal and prepubertal obese chil-
dren was measurable during most seasons, although this 
difference was not as evident in spring, probably due to 
the smaller sample size.
The reasons why vitamin D deficiency is higher in 
obese children during puberty are unknown. Our study is 
descriptive, and as such, it is not meant to provide an etiol-
ogy for this deficiency. However, like other authors (6), we 
suspect that the lower levels of vitamin D observed in obese 
pubertal children are linked to decreased sun exposure 
resulting from a sedentary lifestyle. We also suspect that 
vitamin D intake in both obese and non-obese adolescents 
is lower than in prepubertal children (24). In conclusion, 
we believe that the combination of limited sun exposure, 
lower daily intake of milk and other vitamin D-rich foods, 
coupled with the increased demand of vitamin D due 
to growth and bone remodeling, explains the increased 
vitamin D deficiency observed in obese adolescents.
In recent years, the relationship between vitamin 
D and glucose metabolism has been widely analyzed, 
although the results have been conflicting (4, 6, 8, 25, 
26). In this study, we observed that vitamin D status 
and HOMA SDS differed between obese subjects during 
prepuberty and puberty. Surprisingly, the difference 
observed in the degree of insulin resistance correlated 
with the degree of vitamin D deficiency in obese prepu-
bertal children was not found in obese pubertal chil-
dren. Furthermore, the univariate analysis of HOMA 
SDS and vitamin D levels did not show a significant 
relationship between the two. These data lead us to 
believe that the higher rate of vitamin D deficiency 
in obese adolescents is not related to a higher degree 
of insulin resistance. Unlike vitamin D levels, HOMA 
index does not seem to undergo seasonal variability in 
obese children (4).
Our study has several limitations, such as its cross-
sectional nature, the absence of a nutritional survey, and 
the absence of data about exercise, sun exposure, and 
body composition. In addition, we did not assess parathy-
roid hormone (PTH), alkaline phosphatase, and calcium 
and phosphorus levels. Finally, due to the reduced sample 
size, we could not compare vitamin D levels among the 
different Tanner stages in the four seasons of the year and, 
for that reason, we compared prepubertal and pubertal 
obese children during the entire year.
In conclusion, puberty is an additional risk factor for 
vitamin D deficiency in obese children. On the one hand, 
this increased risk, together with the key role of adoles-
cence in bone formation, makes it important to monitor 
vitamin D levels in obese pubertal children. On the other 
hand, it seems that the more acute deficiency observed in 
obese pubertal children is not related to a higher degree of 
insulin resistance, at least not directly. However, further 
longitudinal studies are required to evaluate the influence 
of puberty on vitamin D levels and its possible relation 
to glucose metabolism. Such studies will be necessary in 
order to design and establish new strategies for preven-
tion and supplementation.
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